Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014

Journal of Clinical Virology

Volumn 62, Issue , 2015, Pages 124-134

  Reusken, Chantal ^a   Niedrig, Matthias ^b   Pas, Suzan ^a   Anda, Pedro ^c   Baize, Sylvain ^d   Charrel, Remi ^e   Di Caro, Antonino ^f   Drosten, Christian ^g   Fernandez Garcia, Maria Dolores ^c   Franco, Leticia ^c   Gunther, Stephan ^h,i   Leparc Goffart, Isabelle ^j   Martina, Byron ^a   Pannetier, Delphine ^k,l   Papa, Anna ^m   Sanchez Seco, Maria Paz ^c   Vapalahti, Olli ^n,o,p   Koopmans, Marion ^a,q  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ROBERT KOCH INSTITUTE   (Germany)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d INSTITUT PASTEUR   (France)

^e Aix Marseille University IRD 190 Inserm 1207   (France)

^f NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^g UNIVERSITY HOSPITAL BONN   (Germany)

^h BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

ⁱ German Center for Infection Research (DZIF)   (Germany)

^j IRBA   (France)

^k Institut Pasteur   (France)

^l INSERM   (France)

^m ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

ⁿ UNIVERSITY OF HELSINKI   (Finland)

^o HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^p UNIVERSITY OF HELSINKI   (Finland)

^q NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

more..

Author keywords

Diagnostics; Ebola virus; Laboratory preparedness; Viral haemorrhagic fever

Indexed keywords

ANTIGEN;

AFRICA; ANTIGEN DETECTION; ARTICLE; BIOSAFETY; EBOLA HEMORRHAGIC FEVER; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; HUMAN; IMMUNE RESPONSE; KNOWLEDGE; LABORATORY; MOLECULAR DIAGNOSTICS; NONHUMAN; PATHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; VIREMIA; VIRUS DIAGNOSIS; ALGORITHM; CLASSIFICATION; EBOLAVIRUS; EPIDEMIC; GENETIC VARIABILITY; GENETICS; HEALTH SURVEY; HEMORRHAGIC FEVER, EBOLA; LABORATORY DIAGNOSIS; MEDICAL GEOGRAPHY; MOLECULAR TYPING; PROCEDURES; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEROTYPING; STANDARDS; TRANSMISSION;

AFRICA, WESTERN; ALGORITHMS; CLINICAL LABORATORY SERVICES; DISEASE OUTBREAKS; EBOLAVIRUS; EUROPE; GENETIC VARIATION; GEOGRAPHY, MEDICAL; HEMORRHAGIC FEVER, EBOLA; HUMANS; MOLECULAR TYPING; POPULATION SURVEILLANCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEROTYPING;

EID: 84920433934     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.11.007     Document Type: Article

References (72)

1. WHO Alert, response, and capacity building under the International Health Regulations (IHR); IHR Procedures concerning public health emergencies of international concern (PHEIC) 2005, WHO, Available from: http://www.who.int/ihr/procedures/pheic/en/.
2. WHO Ebola Response Roadmap Situation Report 2014, Available from: http://apps.who.int/iris/bitstream/10665/137185/1/roadmapupdate25Oct14_eng.pdf?ua=1.
3. WHO Global Alert and Response (GAR). Disease outbreak news; Ebola virus disease outbreak - West Africa 2014, WHO, Available from: http://www.who.int/csr/don/2014_09_04_ebola/en/.
4. WHO Global Alert and Response (GAR). No early end to the Ebola outbreak 2014, WHO, Available from: http://who.int/csr/disease/ebola/overview-20140814/en/.
5. WHO Global Alert and Response (GAR). Ebola virus disease - Democratic Republic of Congo 2014, WHO, Available from: http://www.who.int/csr/don/2014_08_27_ebola/en/.
6. WHO Ebola virus disease update - Senegal 2014, WHO, Available from: http://www.who.int/csr/don/2014_08_30_ebola/en/.
7. WHO Ebola Response Roadmap Situation Report 1 2014, Available from: http://www.who.int/csr/disease/ebola/situation-reports/29-august-2014.pdf?ua=1.
8. ECDC Outbreak of Ebola virus disease in West Africa. ECDC Rapid Risk assessment, Seventh update 2014.
9. WHO Global Alert and Response (GAR). Democratic Republic of Congo: classic Ebola in a country experiencing its seventh outbreak 2014, Available from: http://www.who.int/csr/disease/ebola/ebola-6-months/drc/en/.
10. ECDC Outbreak of Ebola virus disease in West Africa. ECDC Rapid Risk assessment, Fourth update 2014.
11. Gomes M.F.C., Pastore, Piontti A., Rossi L., Chao D., Longini I., Halloran M.E., et al. Assessing the International Spreading Risk Associated with the 2014 West African Ebola Outbreak. PLoS Curr 2014.
12. WHO Ebola Response Roadmap Situation Report 2 2014, Available from: http://www.who.int/csr/disease/ebola/5-september-2014-en.pdf?ua=1.
13. Barrette R.W., Xu L., Rowland J.M., McIntosh M.T. Current perspectives on the phylogeny of Filoviridae. Infect Genet Evol 2011, 11(7):1514-1519.
14. Kuhn J., Becker S., Ebihara H., Geisbert T., Johnson K., Kawaoka Y., et al. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol 2010, 155(12):2083-2103.
15. Baize S., Pannetier D., Oestereich L., Rieger T., Koivogui L., Magassouba N., et al. Emergence of Zaire Ebola virus disease in Guinea - preliminary report. N Engl J Med 2014.
16. Dusa G., Rambaut A. Phylogenetic Analysis of Guinea 2014 EBOV Ebolavirus Outbreak. PloS Curr 2014, 10.1371/currents.outbreaks.84eefe5ce43ec9dc0bf0670f7b8b417d.
17. Gire G., Goba A., Andersen K., Sealfon R., Park D., Kanneh L., et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014, 10.1126/science.1259657.
18. WHO Virological analysis: no link between Ebola outbreaks in West Africa and Democratic Republic of Congo; situation assessment 2 September 2014 2014, WHO.
19. Bausch D.G., Towner J.S., Dowell S.F., Kaducu F., Lukwiya M., Sanchez A., et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 2007, 196(Suppl. 2):S142-S147.
20. Towner J.S., Rollin P.E., Bausch D.G., Sanchez A., Crary S.M., Vincent M., et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004, 78(8):4330-4341.
21. Rowe A.K., Bertolli J., Khan A.S., Mukunu R., Muyembe-Tamfum J.J., Bressler D., et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 1999, 179(Suppl. 1):S28-S35.
22. Ksiazek T.G., Rollin P.E., Williams A.J., Bressler D.S., Martin M.L., Swanepoel R., et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999, 179(Suppl. 1):S177-S187.
23. Leroy E.M., Baize S., Debre P., Lansoud-Soukate J., Mavoungou E. Early immune responses accompanying human asymptomatic Ebola infections. Clin Exp Immunol 2001, 124(3):453-460.
24. Baize S., Leroy E., Georges-Courbot M., Capron M., Lansoud-Soukate J., Debré P., et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999, 5(4):423-426.
25. Kortepeter M.G., Bausch D.G., Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis 2011, 204(Suppl. 3):S810-S816.
26. Wauquier N., Becquart P., Gasquet C., Leroy E.M. Immunoglobulin G in Ebola outbreak survivors, Gabon. Emerg Infect Dis 2009, 15(7):1136-1137.
27. MacNeil A., Reed Z., Rollin P.E. Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus. PLoS Negl Trop Dis 2011, 5(6).
28. Feldmann H. Ebola Haemorrhagic fever. Lancet 2011, 377:849-862.
29. Towner J., Sealy T., Khristova M., Albariño C., Conlan S., Reeder S., et al. Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog 2008, 4(11):e1000212.
30. Ogawa H., Miyamoto H., Ebihara H., Ito K., Morikawa S., Feldmann H., et al. Detection of all known filovirus species by reverse transcription-polymerase chain reaction using a primer set specific for the viral nucleoprotein gene. J Virol Methods 2011, 171(1):310-313.
31. Trombley A., Wachter L., Garrison J., Buckley-Beason V., Jahrling J., Hensley L., et al. Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg 2010, 82(5):954-960.
32. Euler M., Wang Y., Heidenreich D., Patel P., Strohmeier O., Hakenberg S., et al. Development of a panel of recombinase polymerase amplification assays for detection of biothreat agents. J Clin Microbiol 2013, 51(4):1110-1117.
33. Drosten C., Göttig S., Schilling S., Asper M., Panning M., Schmitz H., et al. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol 2002, 40(7):2323-2330.
34. Panning M., Laue T., Olschlager S., Eickmann M., Becker S., Raith S., et al. Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. J Infect Dis 2007, 196(Suppl. 2):S199-S204.
35. Gibb T., Norwood D., Woollen N., Henchal E. Development and evaluation of a fluorogenic 5' nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan. J Clin Microbiol 2001, 39(11):4125-4130.
36. Towner J., Sealy T., Ksiazek T., Nichol S. High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis 2007, 196(Suppl. 2):S205-S212.
37. Kurosak Y., Takada A., Ebihara H., Grolla A., Kamo N., Feldmann H., et al. Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification. J Virol Methods 2007, 141(1):78-83.
38. Zhai J., Palacios G., Towner J., Jabado O., Kapoor V., Venter M., et al. Rapid molecular strategy for filovirus detection and characterization. J Clin Microbiol 2007, 45(1):224-226.
39. Weidmann M., Mühlberger E., Hufert F. Rapid detection protocol for filoviruses. J Clin Virol 2004, 30(1):94-99.
40. Leroy E.M., Baize S., Lu C.Y., McCormick J.B., Georges A.J., Georges-Courbot M.C., et al. Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol 2000, 60(4):463-467.
41. Sanchez A., Ksiazek T., Rollin P., Miranda M., Trappier S., Khan A., et al. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis 1999, 179(Suppl. 1):S164-S169.
42. Grard G., Biek R., Tamfum J., Fair J., Wolfe N., Formenty P., et al. Emergence of divergent Zaire ebola virus strains in Democratic Republic of the Congo in 2007 and 2008. J Infect Dis 2011, 204(Suppl. 3):S776-S784.
43. Morvan J., Deubel V., Gounon P., Nakouné E., Barrière P., Murri S., et al. Identification of Ebola virus sequences present as RNA or DNA in organs of terrestrial small mammals of the Central African Republic. Microbes Infect 1999, 1(14):1193-1201.
44. Stadhouders R., Pas S., Anber J., Voermans J., Mes T., Schutten M. The effect of primer-template mismatches on the detection and quantification of nucleic acids using the 5' nuclease assay. J Mol Diag 2010, 12(1):109-117.
45. Lucht A., Formenty P., Feldmann H., Gotz M., Leroy E., Bataboukila P., et al. Development of an immunofiltration-based antigen-detection assay for rapid diagnosis of Ebola virus infection. J Infect Dis 2007, 196(Suppl. 2):S184-S192.
46. Niedrig M., Schmitz H., Becker S., Günther S., ter Meulen J., Meyer H., et al. First international quality assurance study on the rapid detection of viral agents of bioterrorism. J Clin Microbiol 2002, 42(4):1753-1755.
47. Escadafal C., Paweska J.T., Grobbelaar A., le Roux C., Bouloy M., Patel P., et al. International external quality assessment of molecular detection of Rift Valley fever virus. PLoS Negl Trop Dis 2013, 7(5):e2244.
48. Escadafal C., Olschlager S., Avsic-Zupanc T., Papa A., Vanhomwegen J., Wolfel R., et al. First international external quality assessment of molecular detection of Crimean-Congo hemorrhagic fever virus. PLoS Negl Trop Dis 2012, 6(6):e1706.
49. Donoso Mantke O., Schmitz H., Zeller H., Heyman P., Papa A., Niedrig M., et al. Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe. Euro Surveill 2005, 10(6):102-106.
50. Huang Y., Wei H., Wang Y., Shi Z., Raoul H., Yuan Z. Rapid detection of filoviruses by real-time TaqMan polymerase chain reaction assays. Virol Sin 2012, 27(5):273-277.
51. Le Guenno B., Formenty P., Wyers M., Gounon P., Walker F., Boesch C. Isolation and partial characterisation of a new strain of Ebola virus. Lancet 1995, 345:1271-1274.
52. Muyembe T., Kipasa M. Ebola haemorrhagic fever in Kikwit, Zaire. International Scientific and Technical Committee and WHO Collaborating Centre for Haemorrhagic Fevers. Lancet 1995, 345:1448.
53. Okware S., Omaswa F., Zaramba S., Opio A., Lutwama J., Kamugisha J., et al. An outbreak of Ebola in Uganda. Trop Med Int Health 2002, 7(12):1068-1075.
54. Rollin P., Williams R., Bressler D., Pearson S., Cottingham M., Pucak G., et al. Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis 1999, 179(Suppl. 1):S108-S114.
55. Yu J., Liao H., Gerdon A., Huffman B., Scearce R., McAdams M., et al. Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor. J Virol Methods 2006, 137(2):219-228.
56. Shahhosseini S., Das D., Qiu X., Feldmann H., Jones S., Suresh M. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens. J Virol Methods 2007, 143(1):29-37.
57. Fernandez-Garcia M.D., Negredo A., Papa A., Donoso-Mantke O., Niedrig M., Zeller H., et al. European survey on laboratory preparedness, response and diagnostic capacity for Crimean-Congo haemorrhagic fever, 2012. Euro Surveill 2014, 19(26).
58. Mitchell S., McCormick J. Physicochemical inactivation of Lassa, Ebola and Marbirg viruses and effect on Clinical Laboratory Analyses. J Clin Microbiol 1984, 20(3):486-489.
59. Freeman R., Codd A.A., Selkon J.B. Effect of beta-propriolactone in blood on routine haematologic, biochemical and serological investigations. Lancet 1982, 1:1048-1049.
60. Lloyd G., Bowen E.T.W., Slade J.H.R. Physical and chemical methods of inactivating lassa. Lancet 1982, 1046-1048.
61. Elliott L.H., McCormick J., Johnson K.M. Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol 1982, 16(4):704-708.
62. Tomori O., Bertolli J., Rollin P.E., Fleerackers Y., Guimard Y., De Roo A., et al. Serologic survey among hospital and health center workers during the Ebola hemorrhagic fever outbreak in Kikwit, 1995, Democratic Republic of the Congo. J Infect Dis 1999, 179(Suppl. 1):S98-S101.
63. Sagripanti J-L., Lytle C. Sensitivity to ultraviolet radiation of Lassa,vaccinia, and Ebola viruses dried on surfaces. Arch Virol 2011, 156:489-494.
64. Lucht A., Grunow R., Möller P., Feldmann H.S.B. Development, characterization and use of monoclonal VP40-antibodies for the detection of Ebola virus. J Virol Methods 2003, 111(1):21-28.
65. Loutfy M., Assmar M., Hay Burgess D., Kain K. Effects of viral hemorrhagic fever inactivation methods on the performance of rapid diagnostic tests for Plasmodium falciparum. J Infect Dis 1998, 178:1852-1855.
66. Blow J., Dohm D., Negley D., Mores C. Virus inactivation by nucleic acid extraction reagents. J Virol Methods 2004, 119(2):195-198.
67. Lucht A., Grunow R., Otterbein C., Möller P., Feldmann H., Becker S. Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus. Med Microbiol Immunol 2004, 193(4):181-187.
68. Ikegami T., Niikura M., Saijo M., Miranda M., Calaor A., Hernandez M., et al. Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston Ebola virus nucleoprotein. Clin Diagn Lab Immunol 2003, 10(4):552-557.
69. Niikura M., Ikegami T., Saijo M., Kurane I., Miranda M., Morikawa S. Detection of Ebola viral antigen by enzyme-linked immunosorbent assay using a novel monoclonal antibody to nucleoprotein. J Clin Microbiol 2001, 39(9):3267-3271.
70. Borisevich I., Mikhaĭlov V., Potryvaeva N., Malinkin I., Kirillov A., Krasnianskiĭ V., et al. [Development of the immunoenzyme test-system for detection of Ebola virus antigen]. Vopr Virusol 1996, 41(5):232-234.
71. Merzlikin N., Chepurnov A., Istomina N., Ofitserov V., Vorob'eva M. [Development and application of an immunoenzyme test system for diagnosing Ebola fever]. Vopr Virusol 1995, 40(1):31-35.
72. Ksiazek T., Rollin P., Jahrling P., Johnson E., Dalgard D.C.J.P. Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol 1992, 30(4):947-950.